Assay and Drug Development Technologies

Papers
(The TQCC of Assay and Drug Development Technologies is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
On the Recent Changes to Animal Protection Measures in United States Food and Drug Administration Policy38
Novel Therapeutics Involving Antibiotic Polymer Conjugates for Treating Various Ailments: A Review23
α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line22
A Perspective on Various Facets of Nanoemulsions and its Commercial Utilities22
Beyond the Maze: Recent Advancements in Molecular and Cellular Tethered Drug Delivery Systems15
Identification of Potential Molecular Targets of Doxorubicin for Application in Skin Cancer: A Network Pharmacology and Molecular Docking Perspective14
Mini Review on the Lyophilization: A Basic Requirement for Formulation Development and Stability Modifier13
Investigating the Role of Buzhong Yiqi Decoction on Neurogenic Bladder with Network Pharmacology, Molecular Docking, and In Vitro Assays13
Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells12
Validation of a Novel Supercritical Fluid Extractor/Dryer Combo Instrument11
Liver-Targeting Composite Nanocarrier Delivery System Based on Chitosan Nanoparticles and Phospholipid Complexes11
Targeted Drug Delivery with Nanosponges and Nanocrystals: Innovations, Formulation Strategies, and Applications10
Development and Fabrication of Emodin-Loaded Patches Using Geraniol as a Penetration Enhancer for Transdermal Delivery9
Molecular Mechanism of μ-Opioid Receptor Activation9
One Year as Editor-in-Chief: Building on a New Chapter9
Spatiotemporal Nanocarriers for Circadian-Aligned Drug Delivery: Advances, Challenges, and Future Directions9
Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Assay and Drug Development Technologies8
A Concise Review on Effect of PEGylation on the Properties of Lipid-Based Nanoparticles7
Development and Validation of Reverse-Phase High-Performance Liquid Chromatography Based Bioanalytical Method for Estimation of Simvastatin in Rat's Plasma7
Synthesis of Novel Acrylamide Graft Copolymer of Acacia nilotica Gum for the Stabilization of Melatonin Nanoparticles for Improved Therapeutic Effect: Op7
Unlocking Antioxidant–Anticancer Synergy: An Exploration of Therapeutic Bioactives from Methanolic Extracts of Rubus ellipticus and <7
Identification of Potent, Selective, and Peripherally Restricted Serotonin Receptor 2B Antagonists from a High-Throughput Screen6
Drug Repurposing Patent Applications October–December 20226
Rapid High-Throughput Assay Identified Gemcitabine and Derivatives As Potent Inhibitors Against Multidrug-Resistant Staphylococcus aureus6
Nanoliposomes Embedded Nanocochleates for Codelivery of Artemether and Lumefantrine: An In Vitro and In Vivo 5
In-Silico Design, Synthesis, and Pharmacological Evaluation of Oxadiazole-Based Selective Cyclo-oxygenase-2 Inhibitors5
A Review on Delivery and Bioavailability Enhancement Strategies of Azithromycin5
Novel Pharmaceutical Cocrystal Consisting of Chlorzoxazone and Nicotinamide: A New Promising Carrier for Solubility Augmentation5
Exploring the Therapeutic Potential of Paclitaxel, Naringenin, and Quercetin: Structural Insights, Mechanisms of Action, and Drug Development Perspectives5
Enhanced Cytotoxic Activity of 6-Mercaptopurine–Loaded Solid Lipid Nanoparticles in Hepatic Cancer Treatment5
Pharmacodynamic and Physicochemical Evaluation of Intranasal Zolmitriptan-Loaded Nanostructured Lipid Carriers: for Enhanced Antimigraine Potential5
Future Prospects and Regulatory Pathways for Invasome Technologies in Transdermal Drug Delivery5
In Vitro Antiviral Assays: A Review of Laboratory Methods5
Drug Repurposing Patent Applications January–March 20235
Drug Repurposing Patent Applications: April–June 20245
Revolutionizing Rheumatoid Arthritis Management: Glucocorticoid-Loaded, Folic Acid-Conjugated Piper nigrum -Based Zinc-Oxide Nanoparticles4
Determination of the Toxicity Preferences of Ocular Drug Delivery System by Comparing Two Different Toxicity Bioassays4
Pharmacological Evaluation of Aescin for Neuroprotection in Intracerebroventricular Streptozotocin Model of Alzheimer’s Disease in Experimental Rats4
Computational Prediction and In Vitro Validation of Potential Molecular Targets Associated with Adverse Reactions of Antimicrobial Drugs in Neonates4
Identification of Selective Small Molecule Modulators of mRNA Processing Using a Multiplexed QuantiGene High-Throughput Screening Platform4
Development of Luteolin-Loaded Calcium Alginate and Gum Tragacanth Blend Microbeads for Oral Delivery: In Vitro Characterization, Antioxidant, Antimicrob4
Synthesis, Antimicrobial Evaluation, and In Silico Studies of 2-Substituted-Phenyl-3-(5-Aryl/Heteroaryl Substituted Thiazol-2-yl) Thiazolidin-4-One Deriv4
A Novel In Situ Gelling System of Quercetin/Sulfobutyl-Ether-β-Cyclodextrin Complex-Loaded Chitosan Nanoparticles for the Treatment of Vulvovaginitis4
A Short Appraisal of Biomimetic Hydrogels to Improve Penetration of Poorly Permeable Drugs4
Letter: Addressing False Positives in High-Throughput Screening: A Call for Better Predictive Models4
Healing Potential of Propolis Extract– Passiflora edulis Seed Oil Emulgel Against Excisional Wound: Biochemical, Histopathological, and Cytokines Level E4
0.058138132095337